Related references
Note: Only part of the references are listed.Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism
Yuhua Zhao et al.
CANCER RESEARCH (2011)
Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma
Heisoog Kim et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib
Manabu Morimoto et al.
HEPATOLOGY RESEARCH (2011)
Treatment Monitoring in Gliomas Comparison of Dynamic Susceptibility-Weighted Contrast-Enhanced and Spectroscopic MRI Techniques for Identifying Treatment Failure
Jonathan Voeglein et al.
INVESTIGATIVE RADIOLOGY (2011)
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Ramon C. Sun et al.
MOLECULAR CANCER (2011)
Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib
Jae Hoon Lee et al.
LIVER INTERNATIONAL (2011)
Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer
A. Lemarie et al.
ONCOGENE (2011)
Exploiting Mitochondrial Dysfunction for Effective Elimination of Imatinib-Resistant Leukemic Cells
Jerome Kluza et al.
PLOS ONE (2011)
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors
Luigi Fiume et al.
PHARMACOLOGICAL RESEARCH (2011)
In vivo magnetic resonance spectroscopy of liver tumors and metastases
E. G. W. ter Voert et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol et al.
NATURE REVIEWS CANCER (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Induction of DNA Damage-Inducible Gene GADD45β Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells
Da-Liang Ou et al.
CANCER RESEARCH (2010)
Oligomycin-induced Bioenergetic Adaptation in Cancer Cells with Heterogeneous Bioenergetic Organization
Wenshan Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Efficacy and Safety of Sorafenib in Advanced Hepatocellular Carcinoma Under Daily Practice Conditions
M. W. Welker et al.
JOURNAL OF CHEMOTHERAPY (2010)
Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1α-induced metabolic reprograming
F. Zhao et al.
ONCOGENE (2010)
Metabolic Modulation of Glioblastoma with Dichloroacetate
E. D. Michelakis et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer
Pieter C. Dagnelie et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis
Thomas Amann et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells
Esther Hulleman et al.
BLOOD (2009)
Abnormalities in Glucose Uptake and Metabolism in Imatinib-Resistant Human BCR-ABL-Positive Cells
Douglas J. Kominsky et al.
CLINICAL CANCER RESEARCH (2009)
Induction of Bim Expression Contributes to the Antitumor Synergy Between Sorafenib and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Inhibitor CI-1040 in Hepatocellular Carcinoma
Da-Liang Ou et al.
CLINICAL CANCER RESEARCH (2009)
GLUT1 as a therapeutic target in hepatocellular carcinoma
Thomas Amann et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
2-[18F]-2-Deoxy-D-Glucose (FDG) Uptake in Human Tumor Cells is Related to the Expression of GLUT-1 and Hexokinase II
L. -C. Ong et al.
ACTA RADIOLOGICA (2008)
Role of dichloroacetate in the treatment of genetic mitochondrial diseases
Peter W. Stapoole et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
E. D. Michelakis et al.
BRITISH JOURNAL OF CANCER (2008)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Quantitative evaluation of dichloroacetic acid kinetics in human - a physiologically based pharmacokinetic modeling investigation
Ting Li et al.
TOXICOLOGY (2008)
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
Sebastien Bonnet et al.
CANCER CELL (2007)
Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children
PW Stacpoole et al.
PEDIATRICS (2006)
Efficacy of dichloroacetate as a lactate-lowering drug
PW Stacpoole et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Dichloroacetate toxicokinetics and disruption of tyrosine catabolism in B6C3F1 mice: dose-response relationships and age as a modifying factor
IR Schultz et al.
TOXICOLOGY (2002)
Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease
OA Andreassen et al.
ANNALS OF NEUROLOGY (2001)
Share Paper
